Literature DB >> 19320562

Hemodynamic forces, vascular oxidative stress, and regulation of BMP-2/4 expression.

Anna Csiszar1, Stephanie Lehoux, Zoltan Ungvari.   

Abstract

Changes in the hemodynamic environment (e.g., hypertension, disturbed-flow conditions) are known to promote atherogenesis by inducing proinflammatory phenotypic alterations in endothelial and smooth muscle cells; however, the mechanisms underlying mechanosensitive induction of inflammatory gene expression are not completely understood. Bone morphogenetic protein-2 and -4 (BMP-2/4) are TGF-beta superfamily cytokines that are expressed by both endothelial and smooth muscle cells and regulate a number of cellular processes involved in atherogenesis, including vascular calcification and endothelial activation. This review considers how hemodynamic forces regulate BMP-2/4 expression and explores the role of mechanosensitive generation of reactive oxygen species by NAD(P)H oxidases in the control of BMP signaling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19320562      PMCID: PMC2842584          DOI: 10.1089/ars.2008.2401

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  154 in total

Review 1.  MAP kinases as structural adaptors and enzymatic activators in transcription complexes.

Authors:  John W Edmunds; Louis C Mahadevan
Journal:  J Cell Sci       Date:  2004-08-01       Impact factor: 5.285

Review 2.  Bone morphogenetic proteins and vascular differentiation: BMPing up vasculogenesis.

Authors:  Martin Moser; Cam Patterson
Journal:  Thromb Haemost       Date:  2005-10       Impact factor: 5.249

3.  Bone morphogenetic protein-2 induces proinflammatory endothelial phenotype.

Authors:  Anna Csiszar; Mansoor Ahmad; Kira E Smith; Nazar Labinskyy; Qun Gao; Gabor Kaley; John G Edwards; Michael S Wolin; Zoltan Ungvari
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

4.  Transforming growth factor-beta expression in cardiovascular organs in stroke-prone spontaneously hypertensive rats with the development of hypertension.

Authors:  Yoshiko Tahira; Noboru Fukuda; Morito Endo; Ryo Suzuki; Yukihiro Ikeda; Hiroto Takagi; Koichi Matsumoto; Katsuo Kanmatsuse
Journal:  Hypertens Res       Date:  2002-11       Impact factor: 3.872

5.  Comparative analysis of follistatin-, activin beta A- and activin beta B-mRNA steady-state levels in diverse porcine tissues by multiplex S1 nuclease analysis.

Authors:  O Schneider; R Nau; U Michel
Journal:  Eur J Endocrinol       Date:  2000-05       Impact factor: 6.664

Review 6.  Arterial calcification: a review of mechanisms, animal models, and the prospects for therapy.

Authors:  R Wallin; N Wajih; G T Greenwood; D C Sane
Journal:  Med Res Rev       Date:  2001-07       Impact factor: 12.944

7.  Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension.

Authors:  S D Lee; K R Shroyer; N E Markham; C D Cool; N F Voelkel; R M Tuder
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

8.  Regulation of the promoters for the human bone morphogenetic protein 2 and 4 genes.

Authors:  L M Helvering; R L Sharp; X Ou; A G Geiser
Journal:  Gene       Date:  2000-10-03       Impact factor: 3.688

Review 9.  Bone morphogenetic proteins in vascular calcification.

Authors:  Keith A Hruska; Suresh Mathew; Georges Saab
Journal:  Circ Res       Date:  2005-07-22       Impact factor: 17.367

10.  Additive effects of hypertension and diabetes on renal cortical expression of PKC-alpha and -epsilon and alpha-tubulin but not PKC-beta 1 and -beta 2.

Authors:  Tanya M Osicka; Leileata M Russo; Mei-Lan Qiu; Gail C Brammar; Vicki Thallas; Josephine M Forbes; Wayne D Comper; George Jerums
Journal:  J Hypertens       Date:  2003-12       Impact factor: 4.844

View more
  30 in total

1.  Crossveinless 2 regulates bone morphogenetic protein 9 in human and mouse vascular endothelium.

Authors:  Yucheng Yao; Medet Jumabay; Albert Ly; Melina Radparvar; Anthony H Wang; Raushan Abdmaulen; Kristina I Boström
Journal:  Blood       Date:  2012-04-03       Impact factor: 22.113

2.  Peroxisome proliferator-activated receptor pathway gene polymorphism associated with extent of coronary artery disease in patients with type 2 diabetes in the bypass angioplasty revascularization investigation 2 diabetes trial.

Authors:  Sharon Cresci; Jun Wu; Michael A Province; John A Spertus; Michael Steffes; Janet B McGill; Edwin L Alderman; Maria Mori Brooks; Sheryl F Kelsey; Robert L Frye; Richard G Bach
Journal:  Circulation       Date:  2011-09-12       Impact factor: 29.690

Review 3.  The role of BMPs in endothelial cell function and dysfunction.

Authors:  Laura A Dyer; Xinchun Pi; Cam Patterson
Journal:  Trends Endocrinol Metab       Date:  2014-06-04       Impact factor: 12.015

4.  Stress and stem cells.

Authors:  John Tower
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2012-04-18       Impact factor: 5.814

5.  A role for the endothelium in vascular calcification.

Authors:  Yucheng Yao; Medet Jumabay; Albert Ly; Melina Radparvar; Mark R Cubberly; Kristina I Boström
Journal:  Circ Res       Date:  2013-07-12       Impact factor: 17.367

Review 6.  Concise review: applying stem cell biology to vascular structures.

Authors:  Kristina I Boström; Alan Garfinkel; Yucheng Yao; Medet Jumabay
Journal:  Stem Cells       Date:  2012-03       Impact factor: 6.277

7.  Bone Morphogenetic Protein-Modulator BMPER Regulates Endothelial Barrier Function.

Authors:  Thomas Helbing; Gwendoline Wiltgen; Alexandra Hornstein; Elena Z Brauers; Linus Arnold; Adrian Bauer; Jennifer S Esser; Philipp Diehl; Sebastian Grundmann; Katrin Fink; Cam Patterson; Christoph Bode; Martin Moser
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

8.  Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity.

Authors:  Ryu Watanabe; Tsuyoshi Shirai; Hong Namkoong; Hui Zhang; Gerald J Berry; Barbara B Wallis; Benedikt Schaefgen; David G Harrison; Jennifer A Tremmel; John C Giacomini; Jörg J Goronzy; Cornelia M Weyand
Journal:  J Clin Invest       Date:  2017-06-12       Impact factor: 14.808

9.  Cardiac responses to 24 hrs hyperoxia in Bmp2 and Bmp4 heterozygous mice.

Authors:  R Howden; I Cooley; C Van Dodewaard; S Arthur; S Cividanes; L Leamy; K McCann Hartzell; W Gladwell; J Martin; G Scott; M Ray; Y Mishina
Journal:  Inhal Toxicol       Date:  2013-07-22       Impact factor: 2.724

10.  Bone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathy.

Authors:  Khaled A Hussein; Karishma Choksi; Sara Akeel; Saif Ahmad; Sylvia Megyerdi; Mohamed El-Sherbiny; Mohamed Nawaz; Ahmed Abu El-Asrar; Mohamed Al-Shabrawey
Journal:  Exp Eye Res       Date:  2014-06-06       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.